Replies to post #200200 on Avid Bioservices Inc (CDMO)

[purpledawgs]

Eyebuystox

The poster said median time to progression is 8.2 months vs historical 5.5 months. That is 50% improvement. Sounds encouraging.

The PFS said 4 month PFS is 76%. I read that to mean 76% have not progressed at 4 months. Am I reading it wrong?

Pd

[edcpf]

It's Median Overall Survival, not Average Overall Survival. For your set average is indeed 7.2, but median looks to be 6.5.

Based on known data it sure appears to be that 10+ month events are lacking, but I don't want to speculate more before the full set of data is released. Then we can say for certain whether the company being excited about this trial on multiple CCs had or did not have any substance behind it.

[hayward]

eyebuystocks


I don't know how well that will be received considering sorafenib alone in a phase 3 trial showed a 10 month MOS here:

Are you saying that bavi plus Sorafenib is worse then sorafenib alone ??


TIA Michael